Individualized asparaginase dosing in childhood acute lymphoblastic leukemia

Keyphrases

• L-asparaginase 100%
• Childhood Acute Lymphoblastic Leukemia 100%
• Escherichia Coli 50%
• Polyethylene Glycol 50%
• Therapeutic Drug Monitoring 40%
• Activity Level 40%
• Asparaginase Activity 40%
• Clinical High Risk 30%
• Media Risk 20%
• Individualized Dosing 20%
• Erwinia Asparaginase 20%
• Trough Level 20%
• Hypertriglyceridemia 20%
• Silent Inactivation 20%
• L-asparagine 20%
• Cumulative Incidence 10%
• Standard Risk 10%
• Pediatric Acute Lymphoblastic Leukemia 10%
• Non-associated 10%
• Asparagine Depletion 10%
• Thrombosis 10%
• Intravenous Dose 10%
• Hyperbilirubinemia 10%
• Pancreatitis 10%
• Central Neurotoxicity 10%
• Non-allergic 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Acute Lymphoblastic Leukemia 100%
• Asparaginase 100%
• Escherichia coli 31%
• Macrogol 31%
• Therapeutic Drug Monitoring 25%
• Asparagine 18%
• Allergic Reaction 12%
• Erwinia 12%
• Trough Level 12%
• Hypertriglyceridemia 12%
• Neurotoxicity 6%
• Thrombosis 6%
• Hyperbilirubinemia 6%
• Pancreatitis 6%